You are here: Industry Insights > Japan

News List

Astex Pharmaceuticals and Otsuka Announce Results of the Phase 3 ASCERTAIN Study of the Novel Oral Cedazuridine and Decitabine Fixed-Dose Combination (ASTX727) in Patients with Myelodysplastic Syndromes (MDS) or Chronic Myelomonocytic Leukemia (CMML) drugs
June 13, 2019
Astex Pharmaceuticals and Otsuka Announce Results of the Phase 3 ASCERTAIN Study of the Novel Oral Cedazuridine and Decitabine Fixed-Dose Combination (ASTX727) in Patients with Myelodysplastic Syndromes (MDS) or Chronic Myelomonocytic Leukemia (CMML).
Japan’s PMDA completes inspection of Lupin’s Mandideep facility (Unit-2) biospectrumasia
June 05, 2019
Pharma major Lupin has announced the completion of the Good Manufacturing Practices (GMP) inspection of its Mandideep facility (Unit-2), by the Pharmaceutical and Medical Devices Agency (PMDA), Japan.
Japan’s PMDA completes inspection of Lupin’s Mandideep facility (Unit-2) biospectrumasia
June 05, 2019
Pharma major Lupin has announced the completion of the Good Manufacturing Practices (GMP) inspection of its Mandideep facility (Unit-2), by the Pharmaceutical and Medical Devices Agency (PMDA), Japan.
Novartis' Kymriah to be covered by Japan's national insurance system pharmafile
May 17, 2019
Japan’s national medical insurance system will pay for Novartis’ CAR-T therapy Kymriah following approval from the Central Social Insurance Medical Council.
Daiichi Sankyo launches hypertension drug in Japan biospectrumasia
May 15, 2019
The mineralocorticoid receptor is a receptor for steroid hormones that control the blood’s electrolyte balance
Eisai to sell anti-rheumatic injection in Japan biospectrumasia
May 13, 2019
Eisai Co., Ltd. has entered into a license agreement with medac Gesellschaft für klinische Spezialpräparate mbH (Medac) for the commercialization of its anti-rheumatic agent methotrexate (MTX) subcutaneous injection (pre-filled syringe) in Japan.
Daiichi Sankyo sells Its Nihonbashi building in Japan biospectrumasia
April 28, 2019
As part of Daiichi Sankyo’s efforts toward the realization of its Vision for 2025 of being a “Global Pharma Innovator with competitive advantage in oncology”, the company is prioritizing resource allocation to the oncology therapeutic area
Permobil to launch its new F-Series in Japan biospectrumasia
April 16, 2019
With cutting-edge technology and design, the game-changing F-Series wheelchair brings a new level of mobility, independence and comfort for people living with disabilities
Alvotech, Fuji Pharma Sign Commercialization Agreement contractpharma
April 15, 2019
For the exclusive partnership and supply to commercialize Alvotech’s ustekinumab biosimilar (Stelara) in Japan...
Japanese pharma market set for strong growth in 2019 europeanpharmaceuticalreview
April 15, 2019
The report, published from CPhI Japan 2019, highlights the country as the second fasted growing mature market for solid dose drugs...

Previous page 1 2 3 4 5 6 7 8 9 10 11 Next page